Emilie Pihan

Title: The Innovations of Emilie Pihan: Advancements in RORgamma Modulation

Introduction:

Emilie Pihan, an accomplished inventor based in Toulouse, France, has made significant contributions to the field of pharmaceutical sciences. Her work revolves around the development of novel compounds aimed at advancing therapeutic applications in various diseases. With one patent to her name, Emilie exemplifies the innovative spirit necessary for driving change in medical treatments.

Latest Patents:

Emilie Pihan holds a noteworthy patent titled "Heterocyclic derivatives as RORgamma modulators." This invention provides novel compounds of formula (I) that function as modulators of RORgamma. The patent highlights the potential of these compounds, along with pharmaceutical compositions, to treat diseases where modulation of RORgamma could have therapeutic effects. This includes autoimmune diseases, autoimmune-related diseases, inflammatory diseases, fibrotic diseases, and cholestatic diseases.

Career Highlights:

Emilie is currently associated with Genfit, a prominent company in the biopharmaceutical industry. Her role at Genfit involves extensive research and development activities focusing on innovative therapeutic solutions. Emilie's dedication to her work is evident in her commitment to tackling complex health challenges through scientific inquiry.

Collaborations:

Throughout her career, Emilie has collaborated with esteemed colleagues, including Jean-Francois Delhomel and Robert Walczak. These collaborations reflect a strong network of professionals committed to advancing medical science through innovative research efforts.

Conclusion:

Emilie Pihan's contributions to the field of RORgamma modulation underscore the critical role of inventors in developing solutions for pressing health issues. With her patent and ongoing work at Genfit, Emilie continues to pave the way for advancements in therapeutic applications, demonstrating the importance of innovation in the medical realm.